Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)

Hong Kong · Delayed Price · Currency is HKD

13.40

-0.10 (-0.74%)

Sep 30, 2026, 3:23 PM HKT

Market Cap	2.67B -46.0%
Revenue (ttm)	n/a
Net Income	-155.17M
EPS	-0.78
Shares Out	198.91M
PE Ratio	n/a
Forward PE	22.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	13.40
Previous Close	13.50
Day's Range	13.40 - 13.40
52-Week Range	12.00 - 26.00
Beta	-0.64
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 26, 2026

About HKG:2480

Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, develops human vaccines and therapeutic biologics to prevent and control infectious diseases, and to treat cancer and autoimmune diseases in Mainland China. The company is developing LZ901, a recombinant herpes zoster vaccine for which a biologics license application (BLA) has been submitted; K3, a recombinant human anti-tumor necrosis factor-alpha monoclonal antibody injection that has completed a Phase 1 clinical trial for the treatment of autoimmune diseases, such as rheumatoid ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2001

Employees 213

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2480

Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements